American Well (NYSE:AMWL) Rating Increased to Hold at Wall Street Zen

American Well (NYSE:AMWL) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday.

Other equities analysts have also recently issued reports about the stock. Wells Fargo & Company reduced their price target on shares of American Well from $12.00 to $9.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Stifel Nicolaus dropped their price objective on American Well from $6.00 to $5.00 and set a “hold” rating on the stock in a research note on Friday. Morgan Stanley decreased their target price on American Well from $10.50 to $6.00 and set an “equal weight” rating for the company in a research note on Thursday, December 18th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of American Well in a report on Wednesday, January 21st. One analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, American Well presently has a consensus rating of “Hold” and an average price target of $7.42.

American Well Price Performance

Shares of AMWL stock opened at $5.38 on Friday. The stock has a market cap of $87.99 million, a PE ratio of -0.90 and a beta of 1.36. The stock has a 50-day moving average of $4.68 and a 200-day moving average of $5.47. American Well has a one year low of $3.71 and a one year high of $12.95.

American Well (NYSE:AMWL) last released its quarterly earnings data on Thursday, February 12th. The company reported ($1.52) earnings per share for the quarter, topping the consensus estimate of ($1.59) by $0.07. The business had revenue of $55.31 million for the quarter, compared to analyst estimates of $52.71 million. American Well had a negative net margin of 38.38% and a negative return on equity of 34.07%. As a group, research analysts anticipate that American Well will post -9.34 earnings per share for the current year.

Insider Activity

In other American Well news, insider Dmitry Zamansky sold 6,243 shares of American Well stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $4.85, for a total value of $30,278.55. Following the sale, the insider owned 191,468 shares of the company’s stock, valued at $928,619.80. This trade represents a 3.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Over the last 90 days, insiders sold 14,633 shares of company stock valued at $67,972. Company insiders own 11.82% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of AMWL. Senvest Management LLC raised its position in American Well by 0.3% in the 2nd quarter. Senvest Management LLC now owns 1,312,852 shares of the company’s stock valued at $11,671,000 after buying an additional 4,497 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of American Well by 2.5% during the 3rd quarter. Vanguard Group Inc. now owns 650,102 shares of the company’s stock worth $3,998,000 after acquiring an additional 15,797 shares in the last quarter. Rock Point Advisors LLC raised its holdings in shares of American Well by 49.3% in the third quarter. Rock Point Advisors LLC now owns 259,171 shares of the company’s stock valued at $1,594,000 after purchasing an additional 85,581 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of American Well by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 152,742 shares of the company’s stock worth $750,000 after purchasing an additional 3,450 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in American Well by 36.0% during the third quarter. Dimensional Fund Advisors LP now owns 97,382 shares of the company’s stock worth $599,000 after purchasing an additional 25,798 shares during the last quarter. 56.05% of the stock is currently owned by institutional investors.

Key Stories Impacting American Well

Here are the key news stories impacting American Well this week:

• Positive Sentiment: Q4 results beat consensus: AMWL reported ($1.52) EPS vs. consensus ($1.59) and revenue of $55.31M vs. $52.71M expected — a modest beat that suggests underlying demand. Read More.
• Neutral Sentiment: Earnings call and transcript available; analysts and media are parsing commentary for signs of margin improvement and CAC trends. Read More.
• Neutral Sentiment: Independent write-ups (Zacks, Benzinga) provide metric-by-metric comparisons to estimates and discuss where growth drivers and cost levers may lie. Read More.
• Negative Sentiment: Guidance materially below Street expectations: Q1 revenue guide of $48.0M–$53.0M vs. consensus ~$59.9M, and FY2026 revenue guide of $195M–$205M vs. consensus ~$243.5M — the guidance shortfall is the clearest near-term driver of downward pressure on the stock. Read More.
• Negative Sentiment: Analyst action: Stifel cut its price target to $5.00 and moved to a “hold” — about a 7% downside from the current ~$5.38 level — reinforcing cautious sentiment after the outlook miss. Read More.

About American Well

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.